Clinical Trials in North Carolina

Showing 15101-15120 of 17,526 trials

Dose Finding Study In Subjects With Crow's Feet

NCT01951742

The purpose of this study is to establish the therapeutic range of ANT-1401 in the treatment of Crow's Feet.

Anterios Inc.145 participantsStarted Sep 2013

Miami, Florida, United States • Pinellas Park, Florida, United States • West Palm Beach, Florida, United States +7 more locations

WITHDRAWNPhase 338 miles

An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

NCT02082197

This is an open-study with a 26 week open label treatment period followed by an optional 26 week open label extension. The total treatment period will be 52 weeks.

HypogonadismTestosterone Deficiency

AbbVieStarted Mar 2014

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mesa, Arizona, United States +39 more locations

Dose Finding Study In Subjects With Crow's Feet

An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

Find Trials by Condition in North Carolina

Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma

Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old

Study of Epratuzumab in Systemic Lupus Erythematosus

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Effect of Tyrosine on Behavioral, Physiological and Nutritional Status During Survive, Evade, Resist, Escape (SERE) School

Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Markers and Mechanisms of Vascular Disease in Type II Diabetes

Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy

Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)

Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique

Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette Syndrome

Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Pazopanib in Treating Patients With Metastatic Urothelial Cancer

VA111913 Dysmenorrhoea Efficacy and Safety Proof of Concept